EDAP TMS reported EUR8.81M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AngioDynamics USD 36.57M 3.79M Sep/2025
Boston Scientific USD 1.83B 93M Dec/2025
EDAP TMS EUR 8.81M 1.57M Sep/2025
Henry Schein USD 808M 48M Dec/2025
Medtronic 2.97B 159M Sep/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Veracyte USD 43.31M 8.43M Dec/2025